País: Nova Zelândia
Língua: inglês
Origem: Medsafe (Medicines Safety Authority)
Morphine sulfate pentahydrate 15 mg/mL;
Medsurge Pharma Limited
15 mg/mL
Solution for injection
Active: Morphine sulfate pentahydrate 15 mg/mL Excipient: Hydrochloric acid Nitrogen Sodium chloride Water for injection
Class B1 Controlled Drug
The short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.
Package - Contents - Shelf Life: Ampoule, glass, Type 1 coloured, 1mL - 5 dose units - 30 months from date of manufacture stored at or below 25°C protect from light 24 hours opened stored at 2° to 8°C (Refrigerate, do not freeze) 24 hours diluted stored at 2° to 8°C (Refrigerate, do not freeze) - Ampoule, glass, Type 1 coloured, 1mL - 50 dose units - 30 months from date of manufacture stored at or below 25°C protect from light 24 hours opened stored at 2° to 8°C (Refrigerate, do not freeze) 24 hours diluted stored at 2° to 8°C (Refrigerate, do not freeze)
2019-08-15
NZ CMI EDITION 1.0 OCTOBER 2020 1 MORPHINE SULFATE _MORPHINE SULFATE PENTAHYDRATE _ NEW ZEALAND CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Morphine Sulfate injection. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. The information in this leaflet was last updated on the date listed on the final page. More recent information on the medicine may be available. YOU SHOULD ENSURE THAT YOU SPEAK TO YOUR PHARMACIST OR DOCTOR TO OBTAIN THE MOST UP-TO-DATE INFORMATION ON THE MEDICINE. Those updates may contain important information about the medicine and its use of which you should be aware. All medicines have risks and benefits. Your doctor has weighed the risks of you having Morphine Sulfate injection against the benefits they expect it will give you. IF YOU HAVE ANY CONCERNS ABOUT THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET. You may need to read it again. WHAT MORPHINE SULFATE INJECTION IS USED FOR Morphine is a pain reliever that belongs to a group of medicines called opioid analgesics. Morphine acts in the brain and spinal cord. It is used most commonly for relief of severe pain. It may also be used just before or during an operation to help the anaesthetic work better. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed it for another purpose. Morphine may produce physical dependency if used for a long time (i.e. more than two weeks). Physical dependency means you may experience unpleasant feelings if you stop morphine suddenly. However, it is also important to keep your pain under control. Your doctor can advise you on how to manage this. This medicine is only available with a doctor's prescription. BEFORE YOU USE MORPHINE SULFATE INJECTION _WHEN _ _YOU _ _MUST _ _NOT _ _USE _ _MORPHINE SULFATE INJECTION _ _ _ DO NOT HAVE MORPHINE SULFATE INJECTION IF YOU HAVE EVER HAD AN ALLERGIC REACTION AFT Leia o documento completo
MORPHINE SULFATE NEW ZEALAND DATA SHEET New Zealand Data Sheet Edition 3.0 July 2022 Page 1 of 23 NEW ZEALAND DATA SHEET WARNINGS LIMITATIONS OF USE Because of the risks associated with the use of opioids, morphine should only be used in patients for whom other treatment options, including non-opioid analgesics, are ineffective, not tolerated or otherwise inadequate to provide appropriate management of pain (see section 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE). HAZARDOUS AND HARMFUL USE Morphine poses risks of hazardous and harmful use which can lead to overdose and death. Assess the patient’s risk of hazardous and harmful use before prescribing and monitor the patient regularly during treatment (see section 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE). LIFE-THREATENING RESPIRATORY DEPRESSION Serious, life-threatening or fatal respiratory depression may occur with the use of morphine. Be aware of situations which increase the risk of respiratory depression, modify dosing in patients at risk and monitor patients closely, especially on initiation or following a dose increase (see section 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE). CONCOMITANT USE OF BENZODIAZEPINES AND OTHER CENTRAL NERVOUS SYSTEM (CNS) DEPRESSANTS, INCLUDING ALCOHOL Concomitant use of opioids with other opioid analgesics, benzodiazepines, gabapentinoids, cannabis, sedatives, hypnotics, tricyclic antidepressants, antipsychotics, antihistamines, centrally-active anti- emetics, general anaesthetics, tranquilisers, beta blocker, or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. Limit dosages and durations to the minimum required; and monitor patients for signs and symptoms of respiratory depression and sedation. Caution patients not to drink alcohol while using morphine (see section 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE). 1 PRODUCT NAME MORPHINE SULFATE 2 mg/1 mL (MEDSURGE) solution for injection MORPHINE SULFATE 5 mg/1 mL (MEDSURGE) solutio Leia o documento completo